This is an investigational study. Pembrolizumab is FDA approved and commercially available for the treatment of melanoma and non-small cell lung cancer. Paricalcitol is FDA approved and commercially available for preventing hyperparathyroidism (a type of hormonal disorder). Gemcitabine and nab-paclitaxel are FDA approved and commercially available for the treatment of many cancers, including pancreatic cancer.